Curian Capital’s Avanos Medical AVNS Stock Holding History

Curian Capital’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-14,588	Closed	-$663K	–	601
2014 Q4	$663K	Buy	+14,588	New	+$573K	0.01%	523

Other funds holding AVNS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

RR Partners New York $929M AUM 110.28% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Curian Capital's AVNS Position: Q1 2015 in Review

Curian Capital sold out of Avanos Medical (AVNS) in Q1 2015, closing a stake of 14,588 shares — an estimated $663K sold.

Curian Capital first reported a position in AVNS in Q4 2014 and held it in 1 quarter. The position peaked at $663K in Q4 2014. 448 funds tracked by Wall St. Rank hold AVNS as of Q1 2015.

Curian Capital reported no remaining Avanos Medical position as of Q1 2015 after selling out during the quarter.
Curian Capital sold 14,588 Avanos Medical shares in Q1 2015, an estimated $663K.
Curian Capital first reported a position in Avanos Medical in Q4 2014 and held it in 1 quarter.
Curian Capital's Avanos Medical position peaked at $663K in Q4 2014.
448 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2015.

Based on Curian Capital's 13F filing for Q1 2015, filed 30 Apr 2015.